Interventional procedure overview of radiofrequency ablation as an adjunct to balloon kyphoplasty or percutaneous vertebroplasty for palliation of painful spinal metastases
Closed for comments This consultation ended on at Request commenting lead permission
Existing assessments of this procedure
The National Comprehensive Cancer Network [NCCN] guidelinestates that radiofrequency ablation of bone lesions may be done to reduce pain and prevent skeletal related events. Radiofrequency ablation of bone lesions has proven successful in pain management, especially for those who do not attain adequate analgesia without intolerable effects (Swarm 2020).
European Society for Medical Oncology (ESMO) guidelinesstates that 'RFA can also relieve pain from bone metastases and reduce the tumour burden in bone. Minimally invasive RFA and vertebroplasty or kyphoplasty are used in combination to reduce tumour mass, create a cavity and stabilise the vertebral body' (Coleman R 2020).
A recently published guideline on percutaneous vertebral augmentation recommends treatment with vertebroplasty after different tumour treatments (like RFA) in patients with painful vertebrae due to metastases to achieve pain relief and the consolidation of vertebra (Tsoumakidou G 2017).
NICE guideline on 'metastatic spinal cord compression in adults: risk assessment, diagnosis and management' in section 1.5.1.8 recommends to 'consider vertebroplasty or kyphoplasty for patients who have vertebral metastases and no evidence of metastatic spinal cord compression or spinal instability if they have: mechanical pain resistant to conventional analgesia, or vertebral body collapse' (NICE clinical guideline CG75, 2008).
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions